n (%) | ||
---|---|---|
No. of patients | 45 (100) | |
Gender; Median age (Min - Max), yrs | Female | 24 (53.3); 54 (34 - 76) |
Male | 21 (46.7); 61 (35 - 75) | |
ECOG | 0 | 20 (44.4) |
≥ 1 | 25 (55.6) | |
Tumor Location | Esophageal | 4 (8.9) |
Gastric | 19 (42.2) | |
Colorectal | 22 (48.9) | |
TNM Stage | II | 3 (6.7) |
III | 12 (26.7) | |
IV | 30 (66.7) | |
Treatment Purpose | Adjuvant | 14 (31.1) |
Palliative | 31 (68.9) | |
Chemotherapy Scheme | 5-FU/Cisplatinum | 23 (51.1) |
Other* | 22 (48.9) | |
5FU Mode of Administration | Bolus alone | 15 (33.3) |
Bolus + CI# | 8 (17.8) | |
Continuous infusion | 22 (48.9) |